{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T12:47:41Z","timestamp":1765975661009},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostic Microbiology and Infectious Disease"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.diagmicrobio.2006.10.014","type":"journal-article","created":{"date-parts":[[2007,1,23]],"date-time":"2007-01-23T12:58:18Z","timestamp":1169557098000},"page":"443-446","source":"Crossref","is-referenced-by-count":37,"title":["Cryptococcal meningitis in a patient treated with infliximab"],"prefix":"10.1016","volume":"57","author":[{"given":"Patricia","family":"Mu\u00f1oz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Giannella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maricela","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Soria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier Lopez","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilio","family":"Bouza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib1","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10096-004-1185-6","article-title":"Cavitating pneumonia after treatment with infliximab and prednisone","volume":"23","author":"Arend","year":"2004","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib2","series-title":"Cryptococcus neoformans","first-page":"47","author":"Casadevall","year":"1998"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib3","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1128\/JCM.31.9.2519-2522.1993","article-title":"False-negative cerebrospinal fluid cryptococcal latex agglutination tests for patients with culture-positive cryptococcal meningitis","volume":"31","author":"Currie","year":"1993","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1128\/JCM.14.6.700-702.1981","article-title":"Serum cryptococcal antigen determination in the presence of rheumatoid factor","volume":"14","author":"Eng","year":"1981","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib5","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1186\/ar995","article-title":"Does safety make a difference in selecting the right TNF antagonist?","volume":"6","author":"Fleischmann","year":"2004","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib6","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1378\/chest.124.6.2395","article-title":"Pulmonary cryptococcosis after initiation of anti-tumor necrosis factor-alpha therapy","volume":"124","author":"Hage","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1046\/j.1365-2249.1996.d01-870.x","article-title":"Contribution of tumour necrosis factor-alpha (TNF-alpha) in host defence mechanism against Cryptococcus neoformans","volume":"106","author":"Kawakami","year":"1996","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib8","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1128\/JCM.32.9.2309-2311.1994","article-title":"Evaluation of new monoclonal antibody-based latex agglutination test for detection of cryptococcal polysaccharide antigen in serum and cerebrospinal fluid","volume":"32","author":"Kiska","year":"1994","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib9","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1002\/art.10583","article-title":"Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept","volume":"46","author":"Lee","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib10","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1128\/JCM.43.6.2989-2990.2005","article-title":"Cryptococcal antigen test revisited: significance for cryptococcal meningitis therapy monitoring in a tertiary Chinese hospital","volume":"43","author":"Lu","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib11","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S0002-9343(01)00945-7","article-title":"Reactivation of histoplasmosis after treatment with infliximab","volume":"112","author":"Nakelchik","year":"2002","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib13","first-page":"2997","article-title":"Cryptococcus neoformans","volume":"vol. 2","author":"Perfect","year":"2005"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib14","article-title":"Granulomatous infections and tumor necrosis factor antagonist therapies","author":"Ruderman","year":"2003"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib15","first-page":"606","article-title":"Pneumonia due to Cryptococcus neoformans in a patient receiving infliximab: possible zoonotic transmission from a pet cockatiel","volume":"49","author":"Shrestha","year":"2004","journal-title":"Respir. Care"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib16","series-title":"Program and abstracts of the 40th annual meeting of the Infectious Diseases society of America. October 24\u201327","article-title":"Cryptococcal pneumonia following treatment with infliximab for rheumatoid arthritis for rheumatoid arthritis (abstract)","author":"Starrett","year":"2002"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1086\/319212","article-title":"Inactivated pronase as the cause of false-positive results of serum cryptococcal antigen tests","volume":"32","author":"Stoeckli","year":"2001","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1439-0507.2000.00556.x","article-title":"Case reports. Disseminated cryptococcoses without cryptococcal antigen detection","volume":"43","author":"Tintelnot","year":"2000","journal-title":"Mycoses"},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib19","first-page":"1561","article-title":"Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab","volume":"29","author":"True","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.amjmed.2005.01.029","article-title":"Infliximab therapy in established rheumatoid arthritis: an observational study","volume":"118","author":"Voulgari","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib21","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy (letter)","volume":"344","author":"Warris","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib22","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0272-5231(03)00134-5","article-title":"Drug-induced pulmonary infection","volume":"25","author":"White","year":"2004","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.diagmicrobio.2006.10.014_bib23","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1164\/rccm.200206-563OC","article-title":"Histoplasmosis after treatment with anti-tumor necrosis factor-alpha therapy","volume":"167","author":"Wood","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."}],"container-title":["Diagnostic Microbiology and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0732889306004226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T21:25:39Z","timestamp":1587331539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0732889306004226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0732889306004226"],"URL":"https:\/\/doi.org\/10.1016\/j.diagmicrobio.2006.10.014","relation":{},"ISSN":["0732-8893"],"issn-type":[{"value":"0732-8893","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}